Pulse Brain · Growing Health Evidence Index
Tier 2 — RCT, large cohort or strong causal designPeer-reviewed

Serum Metabolomics Reveals Underlying Mechanisms of Cholesterol‐Lowering Effects of Oat Consumption: A Randomized Controlled Trial in a Mildly Hypercholesterolemic Population

Dengfeng Xu; Shaokang Wang; Meiyuan Feng; Varsha Shete; YiFang Chu; Alison Kamil; Chao Yang; Hechun Liu; Hui Xia; Xin Wang; Guiju Sun; Yuexin Yang

Molecular Nutrition & Food Research · 2021

Read source ↗ All evidence

Summary

This randomised controlled trial examined the mechanistic basis of oat-mediated cholesterol reduction using serum untargeted metabolomics in 62 mildly hypercholesterolaemic Chinese adults. Daily oat consumption (80 g, 3 g beta-glucan) for 45 days reduced total cholesterol by 8.41%, LDL-cholesterol by 13.93%, and non-HDL-cholesterol by 10.93% compared with rice control, whilst serum metabolomic profiling identified 21 significantly altered metabolites predominantly involved in glycerophospholipid, sphingolipid, and amino acid metabolism pathways. The findings suggest oat's lipid-lowering effect operates through modulation of phospholipid and sphingoid base metabolism rather than systemic glucose or triglyceride handling.

Regional applicability

The study was conducted in China and may have limited direct applicability to United Kingdom populations due to potential differences in baseline diet, genetic ancestry, and oat consumption practices. However, the metabolomic mechanisms identified for beta-glucan-enriched oats are likely mechanistically relevant to UK clinical practice, and the cholesterol-lowering efficacy aligns with published European and North American evidence supporting oat-based dietary interventions in dyslipidaemia management.

Key measures

Serum total cholesterol, LDL-cholesterol, non-HDL-cholesterol, triglycerides, apolipoprotein B, glycated albumin, fasting blood glucose; untargeted serum metabolomics with OPLS-DA and pathway analysis (Kyoto Encyclopedia of Gene and Genomes).

Outcomes reported

The study measured serum lipid profiles and untargeted metabolomic signatures in response to oat supplementation (80 g daily, containing 3 g beta-glucan) versus rice control over 45 days. Oat consumption significantly reduced total cholesterol, LDL-cholesterol, and non-HDL-cholesterol, with metabolomic analysis revealing 21 differentially abundant metabolites linked to glycerophospholipid, sphingolipid, and amino acid metabolism.

Theme
Nutrition & health
Subject
Crop nutrient density & mineral composition
Study type
Research
Study design
RCT
Source type
Peer-reviewed study
Status
Published
Geography
China
System type
Arable cereals
DOI
10.1002/mnfr.202001059
Catalogue ID
NRmu83pfct-003

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.